Table 3 Incidence of stroke/CHD and all-cause mortality at follow-up
Outcomes | Normal geometry (n = 7939) | Concentric remodeling (n = 759) | Concentric hypertrophy (n = 426) | Eccentric hypertrophy (n = 816) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
n (%) | Rate per 1000 person-years (95% CI) | n (%) | Rate per 1000 person-years (95% CI) | P value | n (%) | Rate per 1000 person-years (95% CI) | P value | n (%) | Rate per 1000 person-years (95% CI) | P value | |
Overall | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Stroke/CHD | 336 (4.2) | 9.79 (8.74, 10.84) | 73 (9.6) | 23.25 (17.92, 28.59) |  < 0.001 | 67 (15.7) | 39.33 (29.92, 48.75) |  < 0.001 | 92 (11.3) | 27.75 (22.08, 33.42) |  < 0.001 |
 All-cause mortality | 239 (3.0) | 6.85 (5.98, 7.71) | 49 (6.5) | 14.99 (10.79, 19.19) |  < 0.001 | 47 (11.0) | 26.08 (18.57, 33.44) |  < 0.001 | 76 (9.3) | 22.06 (17.10, 27.02) |  < 0.001 |
Male | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Stroke/CHD | 183 (4.8) | 11.08 (9.47, 12.68) | 40 (12.2) | 29.91 (20.64, 39.18) |  < 0.001 | 31 (17.7) | 44.80 (29.03, 60.58) |  < 0.001 | 41 (15.2) | 36.97 (25.65, 48.28) |  < 0.001 |
 All-cause mortality | 129 (3.4) | 7.64 (6.32, 8.96) | 29 (8.8) | 20.70 (13.16, 28.23) |  < 0.001 | 15 (8.6) | 19.96 (9.86, 30.06) |  < 0.001 | 29 (10.8) | 24.94 (15.86, 34.02) |  < 0.001 |
Female | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Stroke/CHD | 153 (3.7) | 8.60 (7.24, 9.96) | 33 (7.7) | 18.31 (12.07, 24.56) |  < 0.001 | 36 (14.3) | 35.59 (23.97, 47.22) |  < 0.001 | 51 (9.3) | 23.11 (16.77, 29.45) |  < 0.001 |
 All-cause mortality | 110 (2.7) | 6.10 (4.96, 7.24) | 20 (4.7) | 10.71 (6.02, 15.41) | 0.02 | 32 (12.7) | 30.31 (19.81, 40.81) |  < 0.001 | 47 (8.6) | 20.60 (14.71, 26.48) |  < 0.001 |